AAAAAA

   
Results: 1-3 |
Results: 3
BLOCKADE OF T-CELL COSTIMULATION WITH CTLA41G (BMS-188667) REVERSES PATHOLOGICAL INFLAMMATION AND KERATINOCYTE ACTIVATION IN PSORIATIC PLAQUES
Authors: KRUEGER JG HAYES E BROWN M KANG S LEBWOHL MG GUZZO CA JEGASOTHY BV GOLDFARB MT HECKER DJ MANN RM ABRAMS JR
Citation: Jg. Krueger et al., BLOCKADE OF T-CELL COSTIMULATION WITH CTLA41G (BMS-188667) REVERSES PATHOLOGICAL INFLAMMATION AND KERATINOCYTE ACTIVATION IN PSORIATIC PLAQUES, Journal of investigative dermatology, 108(4), 1997, pp. 108-108
THE SAFETY OF ETRETINATE AS LONG-TERM THERAPY FOR PSORIASIS - RESULTSOF THE ETRETINATE FOLLOW-UP-STUDY
Authors: STERN RS FITZGERALD E ELLIS CN LOWE N GOLDFARB MT BAUGHMAN RD
Citation: Rs. Stern et al., THE SAFETY OF ETRETINATE AS LONG-TERM THERAPY FOR PSORIASIS - RESULTSOF THE ETRETINATE FOLLOW-UP-STUDY, Journal of the American Academy of Dermatology, 33(1), 1995, pp. 44-52
TOPICAL TRETINOIN (RETINOIC ACID) TREATMENT OF HYPERPIGMENTED LESIONSASSOCIATED WITH PHOTOAGING IN CHINESE AND JAPANESE PATIENTS - A VEHICLE-CONTROLLED TRIAL
Authors: GRIFFITHS CEM GOLDFARB MT FINKEL LJ ROULIA V BONAWITZ M HAMILTON TA ELLIS CN VOORHEES JJ
Citation: Cem. Griffiths et al., TOPICAL TRETINOIN (RETINOIC ACID) TREATMENT OF HYPERPIGMENTED LESIONSASSOCIATED WITH PHOTOAGING IN CHINESE AND JAPANESE PATIENTS - A VEHICLE-CONTROLLED TRIAL, Journal of the American Academy of Dermatology, 30(1), 1994, pp. 76-84
Risultati: 1-3 |